FDA Gets Mixed Advice on Nanotechnology

(AP) -- The government must balance close oversight of the fast-growing field of nanotechnology against the risk of stifling new development, a Food and Drug Administration conference was told Tuesday.

If you want to include this story in your blog, copy and paste this formatted text: